Ethyl 3,5,5-trimethylhexanoate
Common Name: |
Ethyl 3,5,5-trimethylhexanoate |
IUPAC Name: |
ethyl 3,5,5-trimethylhexanoate |
Molecular Formula: |
C7H13NS |
SMILES: |
CCOC(=O)CC(C)CC(C)(C)C |
Inchi: |
1S/C11H22O2/c1-6-13-10(12)7-9(2)8-11(3,4)5/h9H,6-8H2,1-5H3 |
Inchi Key: |
NMZMQQBBZRGLPJ-UHFFFAOYSA-N |
Cas No: |
67707-75-9 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
143.25 |
Mass (g/mol) |
186.162 |
Molar Refractivity |
48.25 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
1 |
Rings |
|
TPSA |
37.66 |
Hetero Atoms |
2 |
Heavy Atoms |
9 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
83.00 to 85.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.47 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.86 |
LogP |
3.012 |
iLOGP |
2.23 |
XLOGP3 |
1.86 |
WLOGP |
1.80 |
MLOGP |
1.35 |
ESOL Log S |
-1.83 |
ESOL Solubility (mg/ml) |
2.1 |
ESOL Solubility (mol/l) |
0.015 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-2.27 |
Ali Solubility (mg/ml) |
0.77 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-1.81 |
Silicos-IT Solubility (mg/ml) |
2.22 |
Silicos-IT Solubility (mol/l) |
0.02 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.85 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.563 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.738 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Warning |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |